Additionally, KEGG enrichment analysis predicted that major pathways involved in the therapeutic effects of BME on UC include the pathway in cancer, prostate cancer, IL-17 signaling pathway and Th17 cell differentiation etc. These pathways primarily contribute to the production of pro-inflammatory cytokines and colon mucosal damage, which are hallmark features of UC. This evidence concerns the gene IL17A and prostate cancer.